Clinical Trial

The Role of Electroencephalography in Caffeine Discontinuation Timing in Premature Infants

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this observational study is to investigate whether functional maturation assessment by electroencephalography in preterm infants can provide reliable data for the safe discontinuation of caffeine therapy without recurrence of apnea. In preterm infants receiving caffeine therapy, an assessment of maturation will be performed by EEG at the time when discontinuation of caffeine treatment is planned.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-02
Trial Details
NCT Number NCT07324941
Lead Sponsor Uludag University
Conditions Apnea Neonatal, Apnea of Prematurity
Enrollment 100 participants
Start Date 2026-01-02
Primary Completion 2027-01-02 (estimated)
Study Completion 2027-01-02 (estimated)
Updated on ClinicalTrials.gov 2026-05-01